FCGR3A and COVID-19: We observed that specific subsets that expanded significantly in COVID-19 exhibited a more potent response to IFN-I including the NK4 subset within NK cells, CM1 within CMs, LDGs within LDNs, CD16+CD8T subset within CD4T/8T, naïve B cells, and PBs.